Egan, K. P., Hook, L. M., Naughton, A., Pardi, N., Awasthi, S., Cohen, G. H., . . . Friedman, H. M. (2020). An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection. PLoS Pathog.

Egan, Kevin P., Lauren M. Hook, Alexis Naughton, Norbert Pardi, Sita Awasthi, Gary H. Cohen, Drew Weissman, and Harvey M. Friedman. "An HSV-2 Nucleoside-modified MRNA Genital Herpes Vaccine Containing Glycoproteins GC, GD, and GE Protects Mice against HSV-1 Genital Lesions and Latent Infection." PLoS Pathog 2020.

Egan, Kevin P., et al. "An HSV-2 Nucleoside-modified MRNA Genital Herpes Vaccine Containing Glycoproteins GC, GD, and GE Protects Mice against HSV-1 Genital Lesions and Latent Infection." PLoS Pathog 2020.